{"DataElement":{"publicId":"66","version":"4","preferredName":"ER Level Tumor Status","preferredDefinition":"indicates the estrogen receptor level measured in a primary tumor or in metastases.","longName":"ER_LVL_TUMOR_STAT","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2015006","version":"1","preferredName":"ER Level","preferredDefinition":"the level of estrogen receptor.","longName":"ER_LVL","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2177156","version":"1","preferredName":"ER","preferredDefinition":"Widely expressed human Estrogen Receptors (NR3 Family) are ligand-activated nuclear hormone receptor transcription factors composed of an N-terminal transcription activation/modulation domain, a DNA-binding domain, and a C-terminal steroid-binding domain. Binding to DNA as a homo- or heterodimer, ESR interacts with NCOA3, NCOA5, and NCOA6 coactivators. Hormone-ESR complexes appear to recognize discrete upstream target ERE DNA sequences to regulate gene expression, cell proliferation, and differentiation. DNA-binding is lost in the absence of ligand. (NCI)","longName":"ER","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Estrogen Receptor Family","conceptCode":"C17069","definition":"Widely expressed human Estrogen Receptors (NR3 Family) are cytoplasmic hormone-activated receptors that act as nuclear transcription factors composed of an N-terminal transcription activation/modulation domain, a DNA-binding domain, and a C-terminal steroid-binding domain. Binding to DNA as a homo- or heterodimer, ESR interacts with NCOA3, NCOA5, and NCOA6 coactivators. Hormone-ESR complexes appear to recognize discrete upstream target ERE DNA sequences to regulate gene expression, cell proliferation, and differentiation. DNA-binding is lost in the absence of ligand. (NCI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7A55-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177479","version":"1","preferredName":"Level","preferredDefinition":"Level; a position on a scale of intensity or amount or quality.","longName":"Level","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Level","conceptCode":"C25554","definition":"A position on a scale measuring intensity, quality, or amount.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-5228-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6E9DE9E-08F1-43C3-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-09-09","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-09-09","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2019266","version":"1","preferredName":"ER Level Tumor Status","preferredDefinition":"the status of the estrogen receptor level.","longName":"ER_LVL_TUMOR_STAT","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"7","maxLength":"8","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Positive","valueDescription":"Positive","ValueMeaning":{"publicId":"2559831","version":"1","preferredName":"Positive","longName":"2559831","preferredDefinition":"Involving advantage or good.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive","conceptCode":"C25246","definition":"Involving advantage or good.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B6C4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2009-10-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8C1BC4C-698D-325D-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-04-23","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Negative","valueDescription":"Negative","ValueMeaning":{"publicId":"2559499","version":"1","preferredName":"Negative","longName":"2559499","preferredDefinition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B578-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-10-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8C1BC4C-698F-325D-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-04-23","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8C1BC4C-6991-325D-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-04-23","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"NOT DONE","valueDescription":"NOT DONE","ValueMeaning":{"publicId":"2559596","version":"1","preferredName":"NOT DONE","longName":"2559596","preferredDefinition":"NOT DONE","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not done","conceptCode":"CL281691","definition":"No value exists.","evsSource":"NCI_META_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B5D9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"061BF83F-6F73-42BD-E044-0003BA3F9857","beginDate":"2005-11-21","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-21","modifiedBy":"ONEDATA","dateModified":"2005-11-21","deletedIndicator":"No"},{"value":"Not done/unknown","valueDescription":"Not done/Unknown","ValueMeaning":{"publicId":"4199732","version":"1","preferredName":"Not done/Unknown","longName":"4199732","preferredDefinition":"Not done/Unknown","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F3F760DD-289E-65B8-E040-BB89AD432AFA","latestVersionIndicator":"Yes","beginDate":"2014-03-06","endDate":null,"createdBy":"BRETTS","dateCreated":"2014-03-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F3F760DD-28D8-65B8-E040-BB89AD432AFA","beginDate":"2014-03-06","endDate":null,"createdBy":"BRETTS","dateCreated":"2014-03-06","modifiedBy":"ONEDATA","dateModified":"2014-03-06","deletedIndicator":"No"},{"value":"Positive, >= 10%","valueDescription":"Positive, >= 10%","ValueMeaning":{"publicId":"6062388","version":"1","preferredName":"Positive, >= 10%","longName":"6062388","preferredDefinition":"Positive, >= 10%","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6491334F-6E70-0F1F-E053-F662850A3EE3","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"SARAHB","dateCreated":"2018-02-06","modifiedBy":"ONEDATA","dateModified":"2018-02-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6491334F-6E89-0F1F-E053-F662850A3EE3","beginDate":"2018-02-06","endDate":null,"createdBy":"SARAHB","dateCreated":"2018-02-06","modifiedBy":"ONEDATA","dateModified":"2018-02-06","deletedIndicator":"No"},{"value":"Positive, 1-9%","valueDescription":"Positive, 1-9%","ValueMeaning":{"publicId":"6062389","version":"1","preferredName":"Positive, 1-9%","longName":"6062389","preferredDefinition":"Positive, 1-9%","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6491334F-6E93-0F1F-E053-F662850A3EE3","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"SARAHB","dateCreated":"2018-02-06","modifiedBy":"ONEDATA","dateModified":"2018-02-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6491334F-6EAC-0F1F-E053-F662850A3EE3","beginDate":"2018-02-06","endDate":null,"createdBy":"SARAHB","dateCreated":"2018-02-06","modifiedBy":"ONEDATA","dateModified":"2018-02-06","deletedIndicator":"No"},{"value":"Positive, <1%","valueDescription":"Positive, <1%","ValueMeaning":{"publicId":"6062390","version":"1","preferredName":"Positive, <1%","longName":"6062390","preferredDefinition":"Positive, <1%","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6491334F-6EB6-0F1F-E053-F662850A3EE3","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"SARAHB","dateCreated":"2018-02-06","modifiedBy":"ONEDATA","dateModified":"2018-02-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6491334F-6ECF-0F1F-E053-F662850A3EE3","beginDate":"2018-02-06","endDate":null,"createdBy":"SARAHB","dateCreated":"2018-02-06","modifiedBy":"ONEDATA","dateModified":"2018-02-06","deletedIndicator":"No"},{"value":">= 10%","valueDescription":">= 10%","ValueMeaning":{"publicId":"6102844","version":"1","preferredName":">= 10%","longName":"6102844","preferredDefinition":">= 10%","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66B7CD99-D011-0E20-E053-F662850A9CB0","latestVersionIndicator":"Yes","beginDate":"2018-03-06","endDate":null,"createdBy":"SARAHB","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66B7CD99-D02A-0E20-E053-F662850A9CB0","beginDate":"2018-03-06","endDate":null,"createdBy":"SARAHB","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","deletedIndicator":"No"},{"value":"<1%","valueDescription":"<1%","ValueMeaning":{"publicId":"6102845","version":"1","preferredName":"<1%","longName":"6102845","preferredDefinition":"<1%","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66B7CD99-D034-0E20-E053-F662850A9CB0","latestVersionIndicator":"Yes","beginDate":"2018-03-06","endDate":null,"createdBy":"SARAHB","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66B7CD99-D04D-0E20-E053-F662850A9CB0","beginDate":"2018-03-06","endDate":null,"createdBy":"SARAHB","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","deletedIndicator":"No"},{"value":"1-9%","valueDescription":"1-9%","ValueMeaning":{"publicId":"3906445","version":"1","preferredName":"1-9%","longName":"3906445","preferredDefinition":"1-9%","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7199E96-D318-C1B4-E040-BB89AD431239","latestVersionIndicator":"Yes","beginDate":"2013-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66B7CD99-D061-0E20-E053-F662850A9CB0","beginDate":"2018-03-06","endDate":null,"createdBy":"SARAHB","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2207929","version":"1","preferredName":"Neoplasm Status","preferredDefinition":"(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.:A condition or state at a particular time.","longName":"C3262:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-359A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6EB07DC-3B2A-43B9-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2005-03-16","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-09-09","modifiedBy":"SARAHB","dateModified":"2018-03-06","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"},{"publicId":"2812245","version":"1","longName":"Phase II Breast Cancer","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811964","version":"1","longName":"Tumor Markers","context":"CTEP"},{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"},{"publicId":"2812156","version":"1","longName":"Breast Cancer DataMart","context":"CTEP"},{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811914","version":"1","longName":"Adjuvant Breast","context":"CTEP"},{"publicId":"2811917","version":"1","longName":"Advanced Breast","context":"CTEP"}]},{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811891","version":"1","longName":"Phase II","context":"CTEP"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2811716","version":"1","longName":"UC Irvine","context":"NCIP"}]},{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"2812502","version":"1","longName":"Unconjugated Isoflavones in Women at High Risk for Breast Cancer","context":"DCP"}]},{"publicId":"2604617","version":"1","longName":"Submission and Reporting","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2812624","version":"1","longName":"Breast Cancer Data Mart","context":"CTEP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4171062","version":"1","longName":"RTOG-1005","context":"NRG"}]}],"AlternateNames":[{"name":"ER_LVL_TUMOR_STAT","type":"C3D Name","context":"CTEP"},{"name":"DCP","type":"USED_BY","context":"DCP"},{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"ER_LVL_TUMOR_STAT","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"Receptor Status, ER","type":"Preferred Question Text","description":"Receptor Status, ER","url":null,"context":"CTEP"},{"name":"COMMENT_211","type":"COMMENT","description":"Add instruction: If measured in fmols/mg cytosol protein >= 10 is positive.  If other measures are used apply institutional standards; borderline results should be reported as positive.","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"ER Status","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"C6EB07DC-3B1B-43B9-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-09-09","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-09-09","modifiedBy":"FORMBUILDER","dateModified":"2014-07-15","changeDescription":"ISO 11179 Compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}